The role of glycosyltransferase enzyme GCNT3 in colon and ovarian cancer prognosis and chemoresistance
Lara P. Fernández(Madrid Institute for Advanced Studies), Ana Ramı́rez de Molina(Madrid Institute for Advanced Studies)
Cited by 50
Related Papers
ABCA1 overexpression worsens colorectal cancer prognosis by facilitating tumour growth and caveolin‐1‐dependent invasiveness, and these effects can be ameliorated using the <scp>BET</scp> inhibitor apabetalone
|Molecular Oncology|2018|108
Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells
|Scientific Reports|2017|75
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancer
|Molecular Oncology|2020|55
Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer
|Nutrients|2017|48
Micro<scp>RNA</scp>‐661 modulates redox and metabolic homeostasis in colon cancer
|Molecular Oncology|2017|19